News

November 4, 2020November 12, 2020

FDA Approves Bronchitol Inhalation Powder as Add-on Treatment for Adult CF Patients

News

The U.S. Food and Drug Administration (FDA) has approved the dry inhalation powder Bronchitol (mannitol) as a maintenance treatment to be used along with other therapies for improving lung ... Read more

November 3, 2020November 3, 2020

Identifying Changes to P. aeruginosa in Lungs May Help With Treatment

cystic fibrosis, News

Pseudomonas aeruginosa mutate into a mucoid form in the lungs of people with cystic fibrosis (CF), creating biofilms that render these bacteria more resistant and more damaging, a study reported. Its ... Read more

October 30, 2020October 30, 2020

Envara Health Launches Encala, Supplement to Enhance Fat Absorption in CF Patients

cystic fibrosis, News

Envara Health has launched Encala (formerly Lym-X-Sorb), a nutritional supplement designed to improve fat and nutrient absorption in people with cystic fibrosis (CF) and pancreatic insufficiency. Encala is indicated ... Read more

October 29, 2020November 2, 2020

Screening for Carriers of CF May Be Cost-free Option for Couples in Australia

cystic fibrosis, News

The Australian Medical Services Advisory Committee (MSAC) has recommended that the costs of screening for mutations known to cause cystic fibrosis (CF), spinal muscular atrophy (SMA), and fragile X syndrome ... Read more

October 28, 2020October 28, 2020

New Machine Learning Technologies Could Improve Disease Prediction in CF

cystic fibrosis, News

Machine learning, a method of data analysis, could improve disease prediction and bring precision medicine for cystic fibrosis (CF) one step closer to reality, according to researchers at the ... Read more

October 27, 2020October 27, 2020

Lenabasum May Help Lessen Flares in CF Patients, Post-hoc Trial Analyses Find

cystic fibrosis, News

Oral lenabasum failed to significantly reduce the frequency of pulmonary exacerbations in people with cystic fibrosis (CF) treated in a Phase 2 trial, but new analyses suggest this failure could be ... Read more

October 26, 2020October 26, 2020

Preclinical Work Supports ELX-02, Potential Treatment for Nonsense Mutations

cystic fibrosis, News

Eloxx Pharmaceuticals presented preclinical safety and efficacy data supporting ELX-02, its investigational treatment for cystic fibrosis (CF) caused by nonsense mutations that is also being evaluated in two enrolling, ... Read more

October 23, 2020October 23, 2020

$200K Donation Will Support Respiratory Care on CF, Other Lung Disorders

cystic fibrosis, News

The National Board for Respiratory Care (NBRC) has launched “CHOOSE ONE: Every Breath Counts Campaign,” a fundraising initiative intended to protect and improve the lives of people who need ... Read more

October 22, 2020October 22, 2020

CFF Award to Advance Synspira’s Treatments for Malabsorption, Lung Infections

cystic fibrosis, News

The Cystic Fibrosis Foundation (CFF) is awarding Synspira Therapeutics up to $14 million in additional funding to support the development of two therapies to address complications of cystic fibrosis (CF), ... Read more

October 21, 2020October 21, 2020

Inhaled Tobramycin Effectively Treats Initial P. aeruginosa Infections in CF

cystic fibrosis, News

Inhaled tobramycin alone works as well at eradicating an initial infection by Pseudomonas aeruginosa bacteria in people with cystic fibrosis (CF), and its use in combination with an oral fluoroquinolone, such ... Read more